Navigation Links
Third Wave reports net loss of $18.9M for 2006

Madison, Wis. - Third Wave Technologies reported a smaller net loss of $18.9 million, or 45 cents per share in 2006, but the company experienced impressive growth in clinical molecular diagnostic revenue, according to a year-end financial report.

Third Wave, which develops molecular diagnostic products for use in clinical testing, said its $18.9 mil......

Full article >>> litigation will cause operating expenses to increase in 2007.


Full article >>>
'"/> By WTN News 02/22/07

Related biology technology :

1. Third Wave files countersuit vs. Digene in patent case
2. Stratagene to pay Third Wave $10.75M in patent case
3. Third Wave responds to Digene patent lawsuit
4. Third Wave seeks approval of Cystic Fibrosis test
5. Third Wave Technologies to raise $14.9M through private debt
6. Third Wave reports $5.2M third quarter loss
7. Third Wave reports another loss, stronger sales
8. Napier joins board of Third Wave Technologies
9. Third Waves revenues rebound
10. Third Wave reports clinical growth, continued loss
11. Third Wave announces two senior management appointments
Post Your Comments:

(Date:11/27/2015)... 27, 2015 /PRNewswire/--  Mallinckrodt plc (NYSE: MNK ... it has closed the sale of its global contrast ... NYSE Euronext) in a transaction valued at approximately $270 ... and a total of approximately 1,000 employees spread across ... St. Louis area. This entire workforce and ...
(Date:11/27/2015)... 27, 2015 ... of companion diagnostics is one of the ... with pharmaceutical companies and diagnostic manufacturers working ... . --> ... on global cancer biomarkers market spread across ...
(Date:11/26/2015)... , England , November 26, 2015 ... Lightpoint Medical, an innovative medical device company specializing in imaging ... grant from the European Commission as part of the Horizon ... the company to carry out a large-scale clinical trial in ... -->      (Logo: , --> ...
(Date:11/25/2015)... 25, 2015  PharmAthene, Inc. (NYSE MKT: PIP) announced ... stockholder rights plan (Rights Plan) in an effort to ... (NOLs) under Section 382 of the Internal Revenue Code ... PharmAthene,s use of its NOLs could be substantially limited ... in Section 382 of the Code. In general, an ...
Breaking Biology Technology:
(Date:11/12/2015)... , Nov. 12, 2015  Arxspan has ... of MIT and Harvard for use of its ... information management tools. The partnership will support the ... biological and chemical research information internally and with ... be used for managing the Institute,s electronic laboratory ...
(Date:11/10/2015)... Nov. 10, 2015  In this report, ... basis of product, type, application, disease indication, ... this report are consumables, services, software. The ... safety biomarkers, efficacy biomarkers, and validation biomarkers. ... are diagnostics development, drug discovery and development, ...
(Date:11/9/2015)... , Nov. 9, 2015  Synaptics Inc. (NASDAQ: ... today announced broader entry into the automotive market with ... match the pace of consumer electronics human interface innovation. ... are ideal for the automotive industry and will be ... Europe , Japan ...
Breaking Biology News(10 mins):